Reuters AstraZeneca asthma drug hits goal, to enter competitive marketReutersL) drive to rebuild its portfolio of new medicines received a boost with positive results for an experimental biotech drug for severe asthma that the company previously flagged as a potential…
AstraZeneca boosted by good results for biotech asthma drug – Reuters
Reuters AstraZeneca boosted by good results for biotech asthma drugReutersLONDON AstraZeneca's (AZN.L) drive to rebuild its portfolio of new medicines received a boost on Tuesday with positive results for a biotech drug for severe asthma that the company has previously…
The asthma talk teens need before they leave for college – Reuters
The asthma talk teens need before they leave for collegeReuters(Reuters Health) – When teens have asthma, the “sex talk” isn't the only tough discussion parents should make sure kids get before heading off to college. The teen years are a…
Yoga may help relieve asthma symptoms – Reuters UK
Yoga may help relieve asthma symptomsReuters UK“Breathing techniques are an essential part of yoga when targeting asthma,” Cramer said. “While posture-based yoga interventions and mere meditation might not be this effective; complex yoga forms (incorporating yoga postures, breathing, and meditation…
Yoga may help relieve asthma symptoms – Reuters
Yoga may help relieve asthma symptomsReuters“Breathing techniques are an essential part of yoga when targeting asthma,” Cramer said. “While posture-based yoga interventions and mere meditation might not be this effective; complex yoga forms (incorporating yoga postures, breathing, and meditation …and…
Yates fails drugs test using asthma inhaler: team – Reuters
BBC News Yates fails drugs test using asthma inhaler: teamReutersLONDON British rider Simon Yates, a strong contender to make Team GB's Olympic cycling squad, has failed a drugs test due to an "administrative error" over the use of an asthma…
BRIEF-Japan approves GlaxoSmithkline’s asthma drug Nucala – Reuters
BRIEF-Japan approves GlaxoSmithkline's asthma drug NucalaReutersMarch 29 Glaxosmithkline Plc. * Receives marketing authorisation for nucala (mepolizumab) in Japan. * Nucala is licensed in japan for adults and adolescents aged 12 years or older Source text for Eikon: Further company coverage:…
Better inhaler lessons can prevent asthma emergencies – Reuters
Reuters Better inhaler lessons can prevent asthma emergenciesReutersReuters Health – A major weakness of asthma care is that many patients don't know how to use inhalers to deliver life-saving medicine when they're gasping for air. The fix may be as…
BUZZ-Vectura: all-time high on completing asthma therapy trial – Reuters
Proactive Investors USA & Canada BUZZ-Vectura: all-time high on completing asthma therapy trialReuters… ** Vectura up over 5 pct to all-time high & top FTSE 250 mid-cap gainer after it completes a clinical trial for generic asthma therapy VR315 in…
Independent group says new Glaxo asthma drug far too expensive – Reuters
Independent group says new Glaxo asthma drug far too expensiveReutersDec 21 An independent nonprofit organization that evaluates clinical and cost effectiveness of new medicines found the price of GlaxoSmithKline's new drug for severe asthma should be as much as 76…